logo.jpg
Zylö’s Erectile Dysfunction Product Concept Wins Best Abstract Award
10 nov. 2021 09h00 HE | Zylö Therapeutics
The product concept uses patent-pending Z-pods™ to sustainably—for over an hour—release nitric oxide GREENVILLE, SC, Nov. 10, 2021 (GLOBE NEWSWIRE) -- A novel nitric-oxide-releasing product concept...
clarus_final_indentity.jpg
Clarus Therapeutics to Present New Real-World Experience Data for JATENZO® (testosterone undecanoate) at the 22nd Annual Fall Scientific Meeting of SMSNA
14 oct. 2021 09h05 HE | Clarus Therapeutics Holdings, Inc.
JATENZO® (testosterone undecanoate) is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in adult males who have deficient testosterone due to certain medical...